Breast Neoplasms: all 12,820 studies
Page 114 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- Lymphedema Prevention in Breast CancerCompletedNCT00760123Not applicable
- A Pilot Study - Comparison of Two Hologic 3D Mammography SystemsCompletedNCT00759447
- Intraoperative Gamma Camera for Breast Cancer SurgeryCompletedNCT00757302Phase 3
- Study of Genes and Environment in Patients With Breast Cancer in the East Anglia Region of the United KingdomStatus unknownNCT00757211
- Case Collection Study for Collecting Images for the Development and Validation of Computer Aided Detection SoftwareTerminatedNCT00756834
- Using Bio Markers to Predict Disease Recurrence and Cognitive Function in High Risk Breast CaCompletedNCT00756132
- Abiraterone Acetate in Treating Postmenopausal Women With Advanced or Metastatic Breast CancerCompletedNCT00755885Phase 1/2
- Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast CancerCompletedNCT00755313
- Vinorelbine Metronomic Plus Lapatinib for Overexpressing HER-2 Metastatic Breast CancerTerminatedNCT00754702Phase 2
- Evaluation of a 3-D Tomosynthesis Mammography System Used in Conjunction With Conventional 2-D Digital MammographyCompletedNCT00754598Not applicable
- Docetaxel, Gemcitabine and Bevacizumab for Metastatic Breast CancerCompletedNCT00754351Phase 2
- A Phase I, Multicenter, Open Label Study on the Effects of SNDX-275 on Expression of Biomarkers in Subjects With Newly Diagnosed Breast CancerTerminatedNCT00754312Phase 1
- Lapatinib and Epirubicin in Treating Patients With Metastatic Breast Cancer. ICORG 06-30CompletedNCT00753207Phase 1
- FEC With G-CSF Support Followed by Ixabepilone With G-CSF Support as Neoadjuvant Chemotherapy in BCCompletedNCT00751868Phase 2
- Collection of Raw Data of Thermal Imaging for the Purpose of Developing a Device for Early Detection of Breast CancerCompletedNCT00750464
- Radiation Therapy Using Gold Markers in Treating Women With Early-Stage Breast CancerCompletedNCT00749437Phase 1
- Collect Breast Cancer Patients' Digital Mammography Images With Corresponding Reports for the Development of SoftwareTerminatedNCT00749255
- Hypnosis in Reducing Pain and Other Side Effects in Women Undergoing Surgery for Breast CancerCompletedNCT00748267Not applicable
- Single-Photon Emission Computed Tomography, Computed Tomography Lymphoscintigraphy, and Intensity-Modulated Radiation Therapy in Treating Patients Who Have Undergone Surgery for Stage I or Stage II Breast CancerCompletedNCT00743314Early Phase 1
- Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast CancerCompletedNCT00742222Phase 4
- Older Patients With Newly Diagnosed Breast Cancer or Colon CancerTerminatedNCT00740961
- Molecular Features Predicting Response/Resistance to Trastuzumab in Metastatic Breast Cancer PatientsCompletedNCT00740532
- Longitudinal Assessment of Arthralgia and Related Symptoms in Breast Cancer Patients Receiving Aromatase InhibitorsTerminatedNCT00738998Not applicable
- Pre-operative Hormonal Treatment for Hormone Receptor Positive Breast CancerSuspendedNCT00738777Phase 2
- An Observational Study of Adherence to Anastrozole in Early Breast Cancer TreatmentCompletedNCT00737009
- Oral Deforolimus With Trastuzumab for Patients With HER2-positive Trastuzumab-Refractory Metastatic Breast Cancer (8669-009)CompletedNCT00736970Phase 2
- Faslodex Registry: Fulvestrant in Current Clinical PracticeCompletedNCT00735215
- Optical Spectroscopy During Breast Cancer Surgery and Core Needle BiopsyCompletedNCT00734838Not applicable
- SCH 727965 in Patients With Advanced Breast and Lung Cancers (Study P04716)CompletedNCT00732810Phase 2
- Digital Mammography: Computer-Aided Breast Cancer DiagnosisCompletedNCT00732433Not applicable
- A Study of GRN163L With Paclitaxel and Bevacizumab to Treat Patients With Locally Recurrent Or Metastatic Breast CancerCompletedNCT00732056Phase 1
- Impact of OncoDoc2 on Guideline Compliance in the Management of Breast CancerCompletedNCT00728442Not applicable
- The Effect of Aspirin on Angiogenesis Proteins in Women on Tamoxifen TherapyCompletedNCT00727948Early Phase 1
- Retrospective Observational Trial on Reasons for Withdraw of Adjuvant Tamoxifen in Breast Cancer PatientsCompletedNCT00727883
- A Yoga and Wellness Program for Breast Cancer Survivors With Persistent FatigueCompletedNCT00727662Not applicable
- Pilot Study to Determine Radioiodide Accumulation and Dosimetry in Breast Cancers Using 124I PET/CTTerminatedNCT00725946Early Phase 1
- A Study to Investigate the Effects of Tibolone (Livial®) on Breast Tissue in Postmenopausal Women With Breast Cancer (Study 32971)(P06469)CompletedNCT00725374Phase 3
- Concomitant Chemoradiotherapy With Weekly Paclitaxel and Vinorelbine and Granulocyte Colony Stimulating Factor (GCSF) Support in Patients With Advanced Breast CancerCompletedNCT00724386Phase 1
- A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid TumorsCompletedNCT00722293Phase 1
- Detection and/or Evaluation of Dense Breast Abnormalities Using Tomosynthesis and Digital MammographyCompletedNCT00722059Early Phase 1
- Three Dimensional (3D) Ultrasound in Predicting Response to Breast Cancer TherapiesCompletedNCT00721903Not applicable
- Taxotere®, Followed by Myocet® and Cyclophosphamide First Line Treatment in HER2 Neg Breast CancerStatus unknownNCT00721747Phase 2
- An Exercise Intervention for Breast Cancer Patients: Feasibility and Effectiveness (BEAT Cancer Trial; Pilot Study)CompletedNCT00721565Phase 1
- Near-Infrared Fluorescent Sentinel Lymph Node Mapping for Breast CancerCompletedNCT00721370Phase 1
- Pre-operative Contrast Enhanced CT to Improve Delineation of the Tumorbed in Radiotherapy for Breast Cancer.CompletedNCT00721058Not applicable
- Effect of Aromatase Inhibitor Therapy on Blood Vessel Function in Postmenopausal Women With Breast CancerCompletedNCT00719966
- HDAC Inhibitor Vorinostat (SAHA) With Capecitabine (Xeloda) Using a New Weekly Dose Regimen for Advanced Breast CancerCompletedNCT00719875Phase 1
- Effect of Aprepitant on Cyclophosphamide Pharmacokinetics in Patients With Breast CancerCompletedNCT00719173Phase 1
- A Randomised,Multi-Center Study of Docetaxol Plus Capecitabine or Cisplatin in Anthracycline-Pretreated Patients With Advanced Breast CancerStatus unknownNCT00717951Phase 2
- A Phase 1b/2a, Open-Label, Multi-Center Study of Tivozanib (AV-951) in Combination With Paclitaxel in Subjects With Advanced or Metastatic Breast CancerCompletedNCT00717340Phase 1
- Tamoxifen Pharmacokinetics and CYP2D6 Polymorphisms in Asian Women With Hormone Receptor Positive Breast CancerCompletedNCT00717015
- A Phase I Cancer Vaccine Study for Patients With Metastatic Breast CancerStatus unknownNCT00715832Phase 1
- Determination of Predictive Value of Echography Doppler AbnormalitiesStatus unknownNCT00714909
- Evaluation of Brain Function Before and After Standard Chemotherapy for Early Breast CancerCompletedNCT00713141
- Determining Quality of Life in Breast Cancer Patient After Completing Radiation,Chemotherapy,Surgery or CombinationWithdrawnNCT00712621Phase 2
- Physician-Patient Communication About Breast Cancer-Related Internet Information and Its Effect on Patient Satisfaction and AnxietyCompletedNCT00712569
- Trastuzumab in Treating Women With HER2-Positive Early Breast CancerStatus unknownNCT00712140Phase 3
- White Button Mushroom Extract in Preventing the Recurrence of Breast Cancer in Postmenopausal Breast Cancer SurvivorsCompletedNCT00709020Phase 1
- Phase I/II Study of AZD2281 Given in Combination With Paclitaxel in Metastatic Triple Negative Breast CancerCompletedNCT00707707Phase 1
- Vaccine Therapy in Treating Women With Previously Treated Metastatic Breast CancerWithdrawnNCT00706615Phase 1
- Vinorelbine Oral Plus Capecitabine Combination In Metastatic Breast CancerCompletedNCT00706069Phase 1
- Docetaxel/Epirubicin/Bevacizumab as First Line Therapy for Metastatic HER2 Negative Breast CancerCompletedNCT00705315Phase 1/2
- Study of CR011-vcMMAE to Treat Locally Advanced or Metastatic Breast CancerCompletedNCT00704158Phase 1/2
- Trial of Blue Citrus Compared to Placebo in Patients Receiving Aromatase Inhibitor Therapy for Estrogen Receptor Positive Post-Menopausal Breast CancerCompletedNCT00702858Not applicable
- The Role of Diet and Lifestyle in Breast Cancer SurvivalStatus unknownNCT00701584
- Using the Conture® Multi-Lumen Balloon to Deliver Accelerated Partial Breast BrachytherapyTerminatedNCT00699101Phase 4
- Chemotherapy on Methylation Patterns in Breast Tumor Tissue Correlating With Clinical Response and OutcomesStatus unknownNCT00698477
- National Survey on Infiltrative Breast CancerCompletedNCT00696527
- Breast Density and the Role of Preoperative Mammography, Ultrasound, Elastography and MRITerminatedNCT00695968
- MRI in Women With Newly Diagnosed Breast Cancer Prior to Breast Conserving SurgeryWithdrawnNCT00695916Phase 3
- Lapatinib and Circulating Tumor Cells in Breast CancerCompletedNCT00694252Phase 2
- Vinorelbine Metronomic Plus Bevacizumab as Salvage Therapy for Breast CancerTerminatedNCT00694200Phase 2
- A Study to Assess the Effects of MK0822 in Reducing the Risk of Bone Metastasis in Women With Breast Cancer (0822-029)WithdrawnNCT00692458Phase 3
- Quality of Life Analysis of Arimidex Treatment in Postmenopausal Patients With Breast CancerCompletedNCT00692289
- Therapy of Metastatic Breast Cancer With Paclitaxel and Liposomal DoxorubicinTerminatedNCT00691912Phase 2
- Dietary Phytoestrogens, Complementary and Alternative Medicine, and Lifestyle in Predicting Survival of Women With Breast CancerStatus unknownNCT00691509
- Weekly Paclitaxel/Carboplatin/Bevacizumab as First Line Therapy for Triple Negative Breast CancerCompletedNCT00691379Phase 1/2
- Relaxation and Visualization Therapy for Breast Cancer PatientsTerminatedNCT00691119Not applicable
- Diet and Exercise or Normal Care in Overweight or Obese Women Who Have Undergone Treatment for Stage I, Stage II, or Stage III Breast CancerCompletedNCT00689975Not applicable
- Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast CancerCompletedNCT00689156Phase 3
- Correlation Between Fluorodeoxyglucose (FDG) and FLT Uptake and Gene-Expression Oncotype Assay in Patients With Breast CancerStatus unknownNCT00688337
- Bone Mineral Density in Postmenopausal Women at Increased Risk of Breast Cancer And Who Are Receiving Exemestane on MAP3CompletedNCT00688246
- Fulvestrant With or Without Lapatinib and/or Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer That Progressed After Previous Aromatase Inhibitor TherapyStatus unknownNCT00688194Phase 3
- Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast CancerStatus unknownNCT00687648Phase 2
- Second-line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast CancerTerminatedNCT00684216Phase 2/3
- Use of Bone Scintigraphy, CT and MRI in Breast CancerStatus unknownNCT00682253
- Cognitive Function in Older Women With Stage I, Stage II, or Stage III Breast Cancer Receiving Hormone TherapyCompletedNCT00681928
- Observational Usage Study of Faslodex in Patients Suffering From Initial Breast Cancer in FranceCompletedNCT00681369
- Ultrasound Based Localization of Lumpectomy Bed in Anatomical Coordinate SystemCompletedNCT00681304
- CARIATIDE (Compliance of ARomatase Inhibitors AssessmenT In Daily Practice Through Educational Approach)CompletedNCT00681122
- Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast CancerCompletedNCT00680758Phase 1
- Clinical Trial of Trametes Versicolor in Women With Breast CancerCompletedNCT00680667Phase 1
- Assessment of Cardiotoxicity After Chemotherapy for Breast Cancer by Cardio-vascular Magnetic Resonance (MR)TerminatedNCT00679874
- Expressive Writing in Improving Quality of Life in Patients With Breast Cancer and LymphedemaCompletedNCT00679185Not applicable
- Phase 2 Trial Of CP-751,871 And Docetaxel In Advanced Breast CancerWithdrawnNCT00678626Phase 2
- Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Breast CancerTerminatedNCT00678509Phase 1/2
- Quantitative Analysis of Outcomes in Breast ReconstructionCompletedNCT00677430
- Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Breast CancerTerminatedNCT00677326Phase 1/2
- Study of Cancer Peptides Vaccine Plus GM-CSF as Adjuvant Treatment for High Risk (TXN2-3M0) or Metastatic Breast Cancer With No Evidence of DiseaseCompletedNCT00674791Phase 1
- Exemestane With or Without ATN-224 in Treating Postmenopausal Women With Recurrent or Advanced Breast CancerTerminatedNCT00674557Phase 2